Perceptive Advisors - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q2 2021$10,754,000
-46.8%
3,392,136
-43.5%
0.07%
-72.7%
Q1 2021$20,220,000
+10712.8%
6,000,000
+3244.1%
0.26%
+5020.0%
Q1 2020$187,000
-68.2%
179,4190.0%0.01%
-58.3%
Q4 2019$588,000
+10.1%
179,4190.0%0.01%
-14.3%
Q3 2019$534,000
+18.1%
179,4190.0%0.01%
+40.0%
Q2 2019$452,000179,4190.01%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q2 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,972,958$4,775,0001.26%
Altium Capital Management LP 1,250,000$3,025,0000.79%
Rubric Capital Management LP 11,300,000$27,346,0000.76%
Vivo Capital, LLC 6,907,189$16,715,0000.75%
DAFNA Capital Management LLC 1,126,613$2,726,0000.72%
SILVERARC CAPITAL MANAGEMENT, LLC 365,661$885,0000.50%
Orbimed Advisors 17,264,764$41,781,0000.46%
Delphi Management Partners VIII, L.L.C. 256,734$621,0000.45%
Endurant Capital Management LP 746,514$1,807,0000.41%
Affinity Asset Advisors, LLC 650,000$1,573,0000.40%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders